Opportunity Information: Apply for PAR 12 172
Apply for PAR 12 172
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Translational Research to Improve Obesity and Diabetes Outcomes (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Sep 20, 2013 and posted on Apr 24, 2012.
- Applicants must submit their applications by Mar 3, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Special district governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) Independent school districts County governments City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Translational Research to Improve Obesity and Diabetes Outcomes (R18) opportunity (Funding Opportunity Number PAR 12-172) is a National Institutes of Health grant program sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It uses the NIH Research Demonstration and Dissemination Project mechanism (R18), which is designed for real-world testing of interventions and implementation approaches rather than early-stage discovery work. The main idea is to take strategies that already have evidence behind them and adapt them so they work in everyday clinical and community settings in a way that is practical, sustainable over time, acceptable to the people and organizations using them, and cost efficient. NIDDK is looking for projects that move beyond proving an intervention can work under ideal conditions and instead focus on how to make it work at scale in the places where patients live and receive care.
The required scientific focus is on improving outcomes related to obesity and diabetes. Proposed research must directly address at least one of the following: prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 diabetes and/or type 2 diabetes, or prevention or delay of complications associated with obesity and diabetes. In other words, projects can range from interventions aimed at reducing obesity risk or helping people achieve meaningful weight loss, to programs that prevent progression to type 2 diabetes among high-risk groups, to care delivery models that improve glycemic control, self-management, adherence, or clinical outcomes for people already living with diabetes. Complication-focused work is also in scope, as long as it centers on preventing or delaying diabetes- or obesity-related downstream harm (for example, cardiovascular, kidney, eye, or neuropathic complications), consistent with the goals described in the announcement.
A central expectation is that applicants will test adaptations of efficacious strategies or approaches. This emphasizes translation and implementation: taking an approach that has demonstrated benefit and modifying it to fit the constraints and realities of target settings such as primary care practices, health systems, schools, workplaces, community organizations, or other community-facing environments. The emphasis on being practical and sustainable signals that NIDDK wants solutions that can be maintained after the study ends, including attention to staffing, workflow, training burden, reimbursement or financing considerations, technology needs, and the cultural and logistical fit for the populations being served. The explicit mention of cost efficiency further suggests that applicants should consider economic implications, resource use, and the likelihood that organizations could adopt the approach without unrealistic ongoing costs.
Dissemination potential is another major theme. The approaches tested should be suitable for broad rollout to clinical practice and to individuals and communities at risk. That means the intervention or program model should be designed with scalability and transferability in mind, rather than being so specialized that it only works in one location with unusual resources. Projects that generate clear, actionable lessons about how to implement, adapt, and deliver effective obesity and diabetes interventions across diverse settings align strongly with the intent of an R18 demonstration and dissemination program. While the summary text does not list specific required methods, the goals of the mechanism point toward strong evaluation plans that measure not only clinical or behavioral outcomes, but also implementation outcomes like reach, adoption, fidelity, acceptability, feasibility, and maintenance, since those factors determine whether dissemination is realistic.
From an administrative standpoint, this is a discretionary grant opportunity in the NIH system under the Food and Nutrition Health activity category, with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). There is no cost sharing or matching requirement, which means applicants are not required to provide matching funds as a condition of receiving the award. The posting date listed is April 24, 2012, with key dates indicating that the opportunity ultimately closed and was archived (current closing date March 3, 2014; archive date April 3, 2014), which is useful for historical reference and for locating the full archived announcement and any successor opportunities.
Eligibility is broad and intentionally inclusive across many organization types that can conduct applied, practice-based research. Eligible applicants include public and private institutions of higher education; nonprofit organizations (including those with 501(c)(3) status and certain nonprofits without 501(c)(3)); for-profit organizations other than small businesses; small businesses; and a wide range of governmental entities such as state governments, county governments, city or township governments, special district governments, and independent school districts. Housing authorities, including public housing authorities and Indian housing authorities, are eligible as well. Tribal eligibility is explicitly addressed, including federally recognized Native American tribal governments and other tribal organizations, as well as tribally controlled colleges and universities (TCCUs). The eligibility notes also highlight other categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal government agencies. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; foreign components are not allowed under NIH policy as referenced in the announcement.
For applicants looking for the official language, requirements, and any application instructions, the opportunity provides an additional information link to the NIH grants guide posting (http://grants.nih.gov/grants/guide/pa-files/PAR-12-172.html). The contact information included is for technical issues accessing or linking to the announcement via the NIH Office of Extramural Research (OER) webmaster email (FBOWebmaster@OD.NIH.GOV), which is mainly for troubleshooting rather than scientific or programmatic guidance.
Overall, this funding opportunity is best understood as support for late-stage translational and implementation-focused research that aims to improve obesity and diabetes outcomes by adapting proven interventions so they can be delivered effectively, affordably, and sustainably in real-world settings, with a clear path to dissemination across clinical practice and at-risk communities.
Frequently Asked Questions (FAQs)
What is the name and funding opportunity number for this grant?
The opportunity is titled Translational Research to Improve Obesity and Diabetes Outcomes (R18) and the Funding Opportunity Number is PAR 12-172.
Which agency and NIH institute sponsor this opportunity?
This is a National Institutes of Health (NIH) grant program sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
What grant mechanism does this opportunity use, and what is it designed to support?
The opportunity uses the NIH Research Demonstration and Dissemination Project mechanism (R18). This mechanism is designed for real-world testing of interventions and implementation approaches, with an emphasis on demonstration and dissemination rather than early-stage discovery or highly controlled efficacy trials.
What is the main goal of the R18 program described in this announcement?
The goal is to take strategies that already have evidence behind them and adapt them so they work in everyday clinical and community settings. Projects are expected to be practical, sustainable over time, acceptable to the people and organizations using them, and cost efficient, with clear potential for dissemination and scale.
What scientific topics must an application address to be responsive?
Proposed research must focus on improving outcomes related to obesity and diabetes and must directly address at least one of the following areas:
- Prevention or reversal of obesity
- Prevention of type 2 diabetes
- Improved care of type 1 diabetes and/or type 2 diabetes
- Prevention or delay of complications associated with obesity and diabetes
Are projects about diabetes complications allowed, and what kinds of complications are in scope?
Yes. Complication-focused work is in scope as long as it centers on preventing or delaying downstream harm associated with obesity or diabetes. Examples mentioned include cardiovascular, kidney, eye, or neuropathic complications, consistent with the aims described in the announcement.
What does "translational" mean in the context of this opportunity?
Here, "translational" refers to moving beyond proving an intervention can work under ideal conditions and instead focusing on how to make it work at scale in real-world places where people live and receive care. The emphasis is on adaptation and implementation in routine settings.
Do projects need to test brand-new interventions?
No. A central expectation is that applicants will test adaptations of efficacious strategies or approaches, meaning strategies that have already demonstrated benefit and are being modified to fit real-world constraints and contexts.
What types of real-world settings are highlighted as relevant for implementation?
The announcement highlights settings such as primary care practices, health systems, schools, workplaces, community organizations, and other community-facing environments where obesity and diabetes prevention or care can realistically be delivered.
What does NIDDK mean by "practical" and "sustainable" approaches?
Practical and sustainable approaches are those that organizations can maintain after the study ends. The announcement signals attention to factors such as staffing, workflow, training burden, reimbursement or financing considerations, technology needs, and cultural and logistical fit for the populations served.
Is cost efficiency an explicit consideration in this funding opportunity?
Yes. The announcement explicitly mentions cost efficiency, suggesting projects should consider economic implications, resource use, and whether organizations could adopt the approach without unrealistic ongoing costs.
What is meant by dissemination potential in this opportunity?
Dissemination potential means the approach should be suitable for broad rollout to clinical practice and to individuals and communities at risk. Projects should be designed with scalability and transferability in mind, rather than being so specialized that they only work in one site with unusual resources.
Does the announcement specify what kinds of outcomes should be evaluated?
While the summary does not list specific required methods, it indicates that strong evaluation plans are consistent with the intent of the R18 mechanism. That includes not only clinical or behavioral outcomes, but also implementation outcomes such as reach, adoption, fidelity, acceptability, feasibility, and maintenance, since those factors drive whether dissemination is realistic.
Is this a discretionary grant, and what activity category is listed?
Yes. Administratively, it is described as a discretionary NIH grant opportunity under the Food and Nutrition Health activity category.
What is the CFDA number associated with this program?
The CFDA number provided is 93.847, listed as Diabetes, Digestive, and Kidney Diseases Extramural Research.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of receiving an award.
Is this opportunity currently open for applications?
No. The key dates indicate it closed and was archived. The current closing date listed is March 3, 2014, and the archive date is April 3, 2014.
Why is the posting date relevant if the opportunity is archived?
The posting date (listed as April 24, 2012) and the archived status are useful for historical reference, for locating the full archived announcement, and for identifying or comparing potential successor opportunities.
Who is eligible to apply?
Eligibility is broad and includes many organization types capable of applied, practice-based research. Eligible applicants include:
- Public and private institutions of higher education
- Nonprofit organizations (including 501(c)(3) and certain nonprofits without 501(c)(3))
- For-profit organizations other than small businesses
- Small businesses
- State, county, city or township governments
- Special district governments
- Independent school districts
- Housing authorities (including public housing authorities and Indian housing authorities)
- Federally recognized Native American tribal governments and other tribal organizations
- Tribally controlled colleges and universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Faith-based or community-based organizations
- Regional organizations
- U.S. territories or possessions
- Eligible federal government agencies
Are foreign institutions eligible to apply?
No. The announcement states that foreign institutions are not eligible to apply.
Are non-U.S. components of U.S. organizations allowed?
No. The eligibility notes indicate that non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed under this opportunity?
No. The announcement indicates foreign components are not allowed under the referenced NIH policy.
Where can applicants find the official announcement text and instructions?
The opportunity provides a link to the NIH Grants Guide posting here: http://grants.nih.gov/grants/guide/pa-files/PAR-12-172.html.
Who should be contacted for technical issues related to accessing or linking to the announcement?
The contact listed for technical issues is the NIH Office of Extramural Research (OER) webmaster email: FBOWebmaster@OD.NIH.GOV. This contact is described as primarily for troubleshooting rather than scientific or programmatic guidance.
What types of projects best fit the intent of this opportunity?
Projects best aligned with this opportunity are late-stage translational and implementation-focused studies that adapt proven obesity and diabetes interventions so they can be delivered effectively, affordably, and sustainably in real-world settings, with a clear path to dissemination across clinical practice and at-risk communities.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Planning Grants for Translational Research to Improve Obesity and Diabetes Outcomes (R34)
Previous opportunity: BLM NV District Office SNPLMA SNPLMA Multiple Species Habitat Conservation Plan Projects under Round 12
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 172
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 172) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning Grants for Translational Research to Improve Obesity and Diabetes Outcomes (R34) Apply for PAR 12 173 Funding Number: PAR 12 173 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Promoting Organ and Tissue Donation Among Diverse Populations (R01) Apply for RFA DK 12 006 Funding Number: RFA DK 12 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Limited Competition for the Continuation of the Halt Polycystic Kidney Disease Trials Data Coordinating Center (DCC) (U01) Apply for RFA DK 12 505 Funding Number: RFA DK 12 505 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of Look AHEAD (Action for Health in Diabetes) Consortium (U01) Apply for RFA DK 12 502 Funding Number: RFA DK 12 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Renal Function and Chronic Kidney Disease in Aging (R01) Apply for PA 12 211 Funding Number: PA 12 211 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Kidney Research Core Centers (P30) Apply for RFA DK 12 008 Funding Number: RFA DK 12 008 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Research Enhancement for NIDDK Hematology Grantees (Admin Supp) Apply for PA 12 242 Funding Number: PA 12 242 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| New Technologies for the Study of Lymphatics in the Digestive and Urinary Systems (R43/R44) Apply for PA 12 258 Funding Number: PA 12 258 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Lymphatics in Health and Disease in the Digestive, Urinary, Cardiovascular and Pulmonary Systems (R01) Apply for PAR 12 259 Funding Number: PAR 12 259 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Lymphatics in Health and Disease in the Digestive, Cardiovascular and Pulmonary Systems (R21) Apply for PAR 12 260 Funding Number: PAR 12 260 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $125,000 |
| Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) Apply for PAR 12 265 Funding Number: PAR 12 265 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of the Assessment, Serial Evaluation and Subsequent Sequelae of Acute Kidney Injury (ASSESS AKI) Study (U01) Apply for RFA DK 12 509 Funding Number: RFA DK 12 509 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Pilot Studies of Candidate Therapies for Chronic Kidney Disease (CKD) (U01) Apply for RFA DK 12 016 Funding Number: RFA DK 12 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expansion of Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) (U01) Apply for RFA DK 12 017 Funding Number: RFA DK 12 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Study (U01) Apply for RFA DK 12 508 Funding Number: RFA DK 12 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Advancing Clinical Research in Primary Glomerular Diseases (UM1) Apply for RFA DK 12 014 Funding Number: RFA DK 12 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Novel Interventions to Reduce Morbidity and Mortality of Hemodialysis Patients Safety and Other Early Phase Studies (U01) Apply for RFA DK 12 010 Funding Number: RFA DK 12 010 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Multidisciplinary K12 Urologic Research (KURe) Career Development Program Apply for RFA DK 12 013 Funding Number: RFA DK 12 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Limited Competition Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) Apply for PAR 12 285 Funding Number: PAR 12 285 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $50,000 |
| George M. OBrien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 12 009 Funding Number: RFA DK 12 009 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $650,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 172", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
